Ciclindole

Ciclindole (INN; WIN-27,147-2), also known as cyclindole (USAN), is an antipsychotic with a tricyclic structure that was never marketed.[1][2] It displaces spiperone binding in vitro and elevates dopamine levels in the striatum, indicating it acts as a D2 receptor antagonist.[2]

Ciclindole
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC14H18N2
Molar mass214.312 g·mol−1
3D model (JSmol)

Synthesis

Cyclindole synthesis: Aram Mooradian; Sterling Drug Inc. U.S. Patent 3,959,309
gollark: Nope!
gollark: > Because smaller groups are shafted by the government.No, the government can't really stop you from forming small organizations and getting equipment and stuff, the issue is that research now requires lots of specialized expensive stuff and lots of people with deep knowledge of subjects together.
gollark: I mean, I think getting something which technically counts as a shelter is possible fairly easily, but not something nice and pleasant like a modern house.
gollark: And most scientific progress is done in bigger groups or organizations now.
gollark: You can't "improve mankind" through scientific research if you do not actually have any of the necessary hardware to do research, and there's rather a lot of it.

See also

References

  1. Triggle DJ (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
  2. Wood PL, McQuade PS (1984). "Ciclindole and flucindole: novel tetrahydrocarbazolamine neuroleptics". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 8 (4–6): 773–7. doi:10.1016/0278-5846(84)90057-5. PMID 6152347.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.